Max Wiznitzer, MD
- Division Chief, Pediatric Neurology and Epilepsy, UH Rainbow Babies and Children's Hospital
- Division Chief, Pediatric Neurology and Epilepsy, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
- Specialty: Pediatric Neurology, Neurology
-
Location:UH Westlake Health Center
960 Clague Rd
Westlake, OH 44145
- Call: 216-844-3691
Biography: Max Wiznitzer, MD
Expertise
Certifications & Memberships
- Neurodevelopmental Disabilities - American Board of Psychiatry and Neurology
- Neurology with Special Qualifications in Child Neurology - American Board of Psychiatry and Neurology
- Pediatrics - American Board of Pediatrics
Education
Research Fellowship | Disorders of Higher Cognitive Function in Children
Disorders of Higher Cognitive Function in Children - Albert Einstein College Of Medicine Of Yeshiva University (1984 - 1986)
Residency | Pediatric Neurology
Pediatric Neurology - Children's Hospital Of Philadelphia (1981 - 1984)
Fellowship | Developmental Disabilities
Developmental Disabilities - Cincinnati Children's Hospital Medical Center (1980 - 1981)
Residency | Pediatrics
Pediatrics - Cincinnati Children's Hospital Medical Center (1977 - 1980)
Medical Education
Northwestern University Feinberg School Of Medicine (1973 - 1977)
Undergraduate
Northwestern University (1975)
About
Watch Dr. Max Wiznitzer’s Health Talks
Max Wiznitzer, MD, is a pediatric neurologist in the Neurologic Institute at University Hospitals Rainbow Babies and Children's Hospital. He is a Professor of Pediatrics and Neurology, Case Western Reserve University School of Medicine.
Dr. Wiznitzer is board certified in pediatrics, neurology with a special qualification in child neurology and neurodevelopmental disabilities. His special interests include attention deficit-hyperactivity disorder (ADHD), autism spectrum disorders, developmental and behavioral disorders, and pediatric neurology. He was named to the UH Rainbow Babies and Children's Hospital staff in 1986.
Dr. Wiznitzer earned a bachelor's degree in medical education from Northwestern University, Evanston, Ill., and his medical degree from Northwestern University Medical School. He completed a pediatrics residency and a fellowship in developmental disorders at Children's Hospital Medical Center, Cincinnati, Ohio, and a fellowship in pediatric neurology at Children's Hospital of Philadelphia, Philadelphia, Pa. He completed his postdoctoral training as a National Institutes of Health National Research fellow in higher cortical functions at Albert Einstein College of Medicine, Bronx, N.Y.
His research interests include autism and pediatric stroke. He has served as Principal Investigator, co-investigator, and consultant on research studies in these areas funded by the National Institutes of Health and other institutions.
Dr. Wiznitzer has authored or co-authored 11 textbook chapters and nearly 70 scientific papers in leading medical journals. He is a reviewer for Neurology, Journal of Child Neurology, Pediatric Neurology, Pediatrics, Lancet Neurology, and Brain and serves on several editorial boards. He has presented more than 50 abstracts and more than 200 lectures at national medical meetings and community, parent and education groups, speaking on autism, ADHD, and other pediatric neurology and development topics.
Dr. Wiznitzer is a member of the American Academy of Pediatrics, American Academy of Neurology, Child Neurology Society, and the Society of Developmental-Behavioral Pediatrics.
Research & Publications
Research Interests
Autism, Behavioral Neurology
Featured Videos
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Max Wiznitzer disclosed the following Outside Relationships with Industry:
- - Novartis Pharmaceuticals - Consulting